Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone vs Standard of Care in Malnourished HIV-Exposed Children
NCT05051163Phase 3Unknown
- Sponsor
- Makerere University
- Start
- Jun 2021
- Primary completion
- Jun 2024
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 3 trial of ceftriaxone in severe acute malnutrition (SAM), sponsored by Makerere University. Status: unknown.
02
Drugs
ceftriaxone
03
Conditions
severe acute malnutrition (SAM)
Beyond the preview
Go deeper on NCT05051163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05051163.